# Sub‐Neuronal Network Profiling of Extracellular Vesicle Release Using a Compartmentalized Neurofluidic Platform

**Authors:** Zeynep Malkoc, Esther Stopps, Prince M. K. Asamoah, Stephanie E. McCalla, Anja Kunze

PMC · DOI: 10.1002/adbi.202500381 · Advanced Biology · 2026-02-18

## TL;DR

This study uses a specialized platform to analyze how neurons release extracellular vesicles in specific locations, revealing how stress and environment affect this process.

## Contribution

The novel contribution is a neurofluidic platform enabling spatially resolved profiling of sub-neuronal EV secretion dynamics.

## Key findings

- The platform reveals regional differences in EV secretion dynamics in cortical, hippocampal, and brainstem neurons.
- EV release is influenced by growth environment, cell maturation time, and exogenous stressors like shear and biochemical stress.
- Okadaic acid treatment alters miRNA expression, suggesting a link to tau-related neurodegeneration.

## Abstract

Extracellular vesicles (EVs) are membrane‐bound vesicles that are secreted by a wide range of organisms and cells, carrying cell‐specific receptors and molecular cargo such as proteins and nucleic acids. EVs have emerged as promising biomarkers for cancer and neurodegenerative disorders like Alzheimer's Disease (AD). Traditional methods for isolating neuron‐derived EVs from bodily fluids or conditioned media are based on bulk analysis methods, such as ultracentrifugation, isolation reagents, and immunoaffinity‐based techniques, and lack spatial resolution to capture localized secretion dynamics. Here, our neurofluidic platform compartmentalizes neuronal networks and enables spatially resolved analysis of EV profiling before subsequent traditional isolation and content screening. This intermediate resolution provides critical insights into localized sub‐neuronal EV secretion dynamics in cortical, hippocampal, and brainstem neurons. Using our platform, the influence of growth environment, cell maturation time, and exogenous stressors such as shear and biochemical stress can be unraveled. Biochemical stress is induced through okadaic acid (OA), a PP1A/PP2A inhibitor, which leads to hyperphosphorylation of proteins. In parallel, microRNA expression profiles are shown after OA treatment in primary neuron cultures, indicating an additional transcriptional response. These findings reveal regional differences in EV secretion dynamics associated with neuronal development and external stressors, including shear forces and PP1A/PP2A inhibition.

This study employs a compartmentalized neurofluidic platform to map extracellular vesicle (EV) secretion dynamics with the aim of increasing the spatial resolution at sub‐neuronal locations. It examines how growth conditions, exogenous forces, and Okadaic acid treatment affect primary neurons' EV release. The study reveals spatially resolved EV dynamics and highlights potential miRNA biomarkers linked to tau‐related neurodegeneration.

## Linked entities

- **Proteins:** PPP1CA (protein phosphatase 1 catalytic subunit alpha), PTPA (protein phosphatase 2 phosphatase activator), MAPT (microtubule associated protein tau)
- **Chemicals:** okadaic acid (PubChem CID 446512)
- **Diseases:** Alzheimer's Disease (MONDO:0004975)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, MIR107 (microRNA 107) [NCBI Gene 406901] {aka MIRN107, miR-107}, MIR212 (microRNA 212) [NCBI Gene 406994] {aka MIRN212, mir-212}, MIR147A (microRNA 147a) [NCBI Gene 406939] {aka MIR147, MIRN147, hsa-mir-147a}, MIR26B (microRNA 26b) [NCBI Gene 407017] {aka MIRN26B, hsa-mir-26b, miR-26b}, MIR922 (microRNA 922) [NCBI Gene 100126321] {aka MIRN922, hsa-mir-922}, PPP1CA (protein phosphatase 1 catalytic subunit alpha) [NCBI Gene 5499] {aka PP-1A, PP1A, PP1alpha, PPP1A}, MIR132 (microRNA 132) [NCBI Gene 406921] {aka MIRN132, miRNA132, mir-132}, BACE1 (beta-secretase 1) [NCBI Gene 23621] {aka ASP2, BACE, HSPC104}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, PPA1 (inorganic pyrophosphatase 1) [NCBI Gene 5464] {aka HEL-S-66p, IOPPP, PP, PP1, SID6-8061}, Bag2 (BCL2-associated athanogene 2) [NCBI Gene 213539] {aka 2610042A13Rik}, PTPA (protein phosphatase 2 phosphatase activator) [NCBI Gene 5524] {aka PARK25, PP2A, PPP2R4, PR53}, SP1 (Sp1 transcription factor) [NCBI Gene 6667], MIR34A (microRNA 34a) [NCBI Gene 407040] {aka MIRN34A, miRNA34A, mir-34, mir-34a}, Ppp1ca (protein phosphatase 1 catalytic subunit alpha) [NCBI Gene 24668] {aka PP1alpha}, MIR215 (microRNA 215) [NCBI Gene 406997] {aka MIRN215, miRNA215, mir-215}, CEL (carboxyl ester lipase) [NCBI Gene 1056] {aka BAL, BSDL, BSSL, CELL, CEase, FAP}, Ppm1a (protein phosphatase, Mg2+/Mn2+ dependent, 1A) [NCBI Gene 24666] {aka Pp2c1}
- **Diseases:** neurodegeneration (MESH:D019636), inflammation (MESH:D007249), neuroinflammation (MESH:D000090862), cancer (MESH:D009369), AD (MESH:D000544), neurological disorders (MESH:D009461), tauopathies (MESH:D024801), cardiovascular diseases (MESH:D002318), OA (MESH:D011015), neuronal networks (MESH:D009410)
- **Chemicals:** phosphate (MESH:D010710), ethane (MESH:D004980), water (MESH:D014867), GlutaMAX (MESH:C054122), B-27 (-), lipid (MESH:D008055), CO2 (MESH:D002245), polydimethylsiloxane (MESH:C013830), ROS (MESH:D017382), DMSO (MESH:D004121), OA (MESH:D019319)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914630/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914630/full.md

## References

99 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914630/full.md

---
Source: https://tomesphere.com/paper/PMC12914630